Detalles de la búsqueda
1.
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.
J Clin Oncol
; 20(3): 727-31, 2002 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11821454
2.
Systemic effects of pegylated recombinant human megakaryocyte growth and development factor in combination with recombinant murine granulocyte colony-stimulating factor in a murine model of myelosuppression.
Toxicol Sci
; 45(1): 77-87, 1998 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-9848114
3.
Fixed-dose pegfilgrastim is safe and allows neutrophil recovery in patients with non-Hodgkin's lymphoma.
Leuk Lymphoma
; 44(10): 1691-6, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14692520
4.
Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis.
Cytokines Cell Mol Ther
; 6(1): 47-56, 2000 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-10976539
Resultados
1 -
4
de 4
1
Próxima >
>>